Role of GLP‐1 Receptor Agonists in Managing Cancer Therapy–Related Cardiac Dysfunction
Among patients with CTRCD receiving guideline-directed medical therapy, GLP-1 RA use may be linked to better 1-year survival and improved heart failure-related outcomes.
Authors
- San Kim (ORCID: https://orcid.org/0000-0002-7122-8665)
- Hyunjun Ahn (ORCID: https://orcid.org/0000-0002-5353-4845)
- Gautam Shah (ORCID: https://orcid.org/0000-0001-8759-3950)
- Shimoli V. Barot (ORCID: https://orcid.org/0000-0002-5313-9992)
- Moath Albliwi (ORCID: https://orcid.org/0009-0003-1914-0054)
- Aleksandar Izda (ORCID: https://orcid.org/0009-0008-9796-9913)
- Aravinthan Vignarajah (ORCID: https://orcid.org/0000-0002-3758-0024)
- Nishanthi Vigneswaramoorthy
- Faris Naffa (ORCID: https://orcid.org/0000-0002-7069-6424)
Institutions
- Saint Agnes Hospital (US)
- Cleveland Clinic (US)
- Ascension (US)
- SUNY Upstate Medical University (US)
- Cleveland Foundation (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Upstate University Hospital (US)
- Fairview Southdale Hospital (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1161/jaha.125.040919
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88